SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that the United States Patent and Trademark Office issued US Patent No.11,359,244 on June 14, 2022. The patent, titled “CHARACTERIZATION OF MOLECULES IN NANOFLUIDICS” claims methods for the analysis of small nucleic acid fragments in nanochannel arrays, which Bionano has traditionally used to analyze ultra-high […]
Protein Metrics received patents across several application areas – data compression, interactive analysis and intact mass reconstruction CUPERTINO, Calif. — Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software and part of the Dotmatics family of scientific R&D software, announced today the granting of three new US patents. The patent names and numbers […]
Bagneux (France) – Genomic Vision (the “Company” – FR0011799907 – GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announces the successful publication of the patent on “Physical Characterization of Telomeres” (PCT). The patent was granted by the U.S. Patent and Trademark Office […]
Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to report that India Patent No. 397884 was granted on May 27, 2022. This patent covers methods and compositions for use of CRISPR/Cas9 and chimeric Cas9 in all cell types including eukaryotic cells. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to this foundational CRISPR/Cas9 […]
Dublin, Ireland: The Opposition Division of the European patent office has maintained European Patent Number 3401400 over challenges from several groups, reinforcing this strong foundational CRISPR patent in Europe. European Patent 3401400 (‘EP400’) has withstood formal opposition at the European Patent Office (‘EPO’) with only minor modifications. The decision by the EPO Opposition Division (‘OD’) […]
Granted by the United States Patent and Trademark Office, with extensions filed globally, the patent covers an approach that gives laboratories the ability to increase productivity for time and cost efficiencies. GOTHENBURG, Sweden — Biosero, Inc., a BICO company and developer of laboratory automation solutions to orchestrate scientific discoveries, announced the issuance of a key patent underlying its […]
IP covers novel method for assembly and error removal in DNA synthesis on silicon chips Patented technology will enable a new generation of in-lab DNA synthesis platforms Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has been granted a European patent covering its unique Binary Assembly […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, today announced that the United States Patent and Trademark Office issued two new US Patents, No. 11,291,999 and No. 11,292,713 on April 5, […]
IP covers proprietary thermally-controlled synthesis chemistry, as well as design and manufacture of silicon chips Patented technology will enable highly parallel DNA synthesis in a benchtop platform Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has been granted patent EP3551331B1 in Europe for its proprietary […]
MGI is pleased that the Court in the Northern District of California denied Illumina’s request to overturn the jury’s decision invalidating the ‘444 patent. The 444 patent was not set to expire until June 2023. Because the other patents Illumina asserted against MGI’s CoolMPSTM technology expire in August 2022, MGI now has the ability to commercialize […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
